Stockscreener 앱 받기
1.47
1.38%
0.02
시간 외 거래:
1.47
전일 마감가:
$1.45
열려 있는:
$1.45
하루 거래량:
54,603
Relative Volume:
0.09
시가총액:
$5.60M
수익:
$556.00K
순이익/손실:
$-5.28M
주가수익비율:
-0.6869
EPS:
-2.14
순현금흐름:
$-6.23M
1주 성능:
-8.13%
1개월 성능:
-0.68%
6개월 성능:
-50.17%
1년 성능:
-53.92%
1일 변동 폭
$1.4001
$1.51
1주일 범위
$1.4001
$1.64
52주 변동 폭
$1.28
$6.25
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
명칭
Cyclerion Therapeutics Inc
전화
617-621-7722
주소
301 BINNEY STREET, CAMBRIDGE, MA
CYCN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
1.47 | 5.52M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.31 | 115.75B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
779.36 | 80.71B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
407.73 | 52.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
852.04 | 52.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.76 | 37.29B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-20 | 개시 | Truist | Buy |
| 2021-09-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-03 | 개시 | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc 주식(CYCN)의 최신 뉴스
Is Cyclerion Therapeutics Inc. stock a safe buy before earningsJuly 2025 Highlights & Capital Protection Trading Alerts - Улправда
Should I hold or sell Cyclerion Therapeutics Inc. stock in 20252025 Geopolitical Influence & Technical Pattern Recognition Alerts - ulpravda.ru
Will Cyclerion Therapeutics Inc. stock benefit from upcoming earnings reports2025 Fundamental Recap & Stock Portfolio Risk Management - ulpravda.ru
Will Cyclerion Therapeutics Inc. stock reach all time highs in 2025 - Улправда
Cyclerion Therapeutics (NASDAQ:CYCN) Shares Down 0.7% – Should You Sell? - Defense World
Cyclerion Therapeutics Earnings Notes - Trefis
Cyclerion Therapeutics Inc. (CYCN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Can Cyclerion Therapeutics Inc. stock sustain institutional interestTrade Performance Summary & Safe Swing Trade Setups - Newser
Does Cyclerion Therapeutics Inc. stock trade at a discount to peersWeekly Loss Report & Verified Momentum Watchlists - Newser
How currency fluctuations impact Cyclerion Therapeutics Inc. stockJuly 2025 Sector Moves & Low Risk High Win Rate Stock Picks - Newser
Cyclerion Therapeutics (CYCN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Cyclerion Therapeutics Inc. stock attractive for growth ETFsPortfolio Risk Report & Free Long-Term Investment Growth Plans - Newser
Cyclerion Receives Milestone Payment from Akebia - TipRanks
Cyclerion Therapeutics Announces Milestone Payment from Akebia - TradingView — Track All Markets
Akebia Therapeutics, Inc. Initiates Phase 2 Clinical Trials for the Treatment of Focused Segmental Glomerulosclerosis Using Praliciguat - marketscreener.com
Cyclerion Therapeutics, Inc. Announces Revision in Its Stock Evaluation Amid Financial Trends - Markets Mojo
How strong is Cyclerion Therapeutics Inc. stock balance sheetBond Market & Real-Time Stock Movement Alerts - newser.com
Will Cyclerion Therapeutics Inc. stock maintain growth story2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Smart tools for monitoring Cyclerion Therapeutics Inc.’s price actionStop Loss & Fast Gain Stock Trading Tips - newser.com
What institutional flow reveals about Cyclerion Therapeutics Inc.Quarterly Profit Report & AI Forecasted Entry and Exit Points - newser.com
Combining machine learning predictions for Cyclerion Therapeutics Inc.Weekly Stock Summary & Daily Volume Surge Signals - newser.com
Tick level data insight on Cyclerion Therapeutics Inc. volatilityRecession Risk & Trade Opportunity Analysis - newser.com
Why Cyclerion Therapeutics Inc. stock is recommended by analystsEarnings Performance Report & Fast Entry Momentum Trade Alerts - newser.com
Cyclerion Therapeutics Inc Stock Analysis and ForecastPrice-to-Book Ratio Updates & High Return Wealth Plans - earlytimes.in
What MACD and RSI say about Cyclerion Therapeutics Inc.July 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
Is Cyclerion Therapeutics Inc. stock reversal real or fakeJuly 2025 Outlook & Real-Time Stock Price Movement Reports - newser.com
Live market analysis of Cyclerion Therapeutics Inc.Weekly Investment Recap & Expert Curated Trade Ideas - newser.com
Is Cyclerion Therapeutics Inc. stock a top pick in earnings seasonWeekly Stock Report & Short-Term Trading Opportunity Alerts - Fundação Cultural do Pará
Is Cyclerion Therapeutics Inc a good long term investmentLong-Term Growth Stocks & You’ve Never Seen Stock Picks Like These - earlytimes.in
Comparing Cyclerion Therapeutics Inc. in custom built stock radarsWeekly Loss Report & Reliable Price Breakout Alerts - newser.com
Cyclerion Therapeutics, Inc. SEC 10-Q Report - TradingView
Cyclerion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] Cyclerion Therapeutics, Inc. Quarterly Earnings Report | CYCN SEC FilingForm 10-Q - Stock Titan
Short interest data insights for Cyclerion Therapeutics Inc.Weekly Trend Report & Fast Moving Market Watchlists - newser.com
Prepare Yourself for Liftoff: Cyclerion Therapeutics Inc (CYCN) - Setenews
Insider Stock Buying Reaches US$525.0k On Cyclerion Therapeutics - Yahoo Finance
Can Cyclerion Therapeutics Inc. stock deliver surprise earnings beatJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network - Benzinga
Cyclerion Therapeutics Inc (CYCN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
1.93%
자본화:
|
볼륨(24시간):